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Myc overexpression enhances 
epicardial contribution to the 
developing heart and promotes 
extensive expansion of the 
cardiomyocyte population
Cristina Villa del Campo1,*, Ghislaine Lioux1,*, Rita Carmona2,3, Rocío Sierra1,  
Ramón Muñoz-Chápuli2,3, Cristina Clavería1 & Miguel Torres1
Myc is an essential regulator of cell growth and proliferation. Myc overexpression promotes the 
homeostatic expansion of cardiomyocyte populations by cell competition, however whether this 
applies to other cardiac lineages remains unknown. The epicardium contributes signals and cells to 
the developing and adult injured heart and exploring strategies for modulating its activity is of great 
interest. Using inducible genetic mosaics, we overexpressed Myc in the epicardium and determined 
the differential expansion of Myc-overexpressing cells with respect to their wild type counterparts. 
Myc-overexpressing cells overcolonized all epicardial-derived lineages and showed increased ability 
to invade the myocardium and populate the vasculature. We also found massive colonization of the 
myocardium by Wt1Cre-derived Myc-overexpressing cells, with preservation of cardiac development. 
Detailed analyses showed that this contribution is unlikely to derive from Cre activity in early 
cardiomyocytes but does not either derive from established epicardial cells, suggesting that early 
precursors expressing Wt1Cre originate the recombined cardiomyocytes. Myc overexpression does 
not modify the initial distribution of Wt1Cre-recombined cardiomyocytes, indicating that it does not 
stimulate the incorporation of early expressing Wt1Cre lineages to the myocardium, but differentially 
expands this initial population. We propose that strategies using epicardial lineages for heart repair may 
benefit from promoting cell competitive ability.
The epicardium is the mesothelium-derived outer layer of the heart. Epicardial cells derive from the proepicar-
dium -a group of cells that bulges from the dorsal pericardial wall-, and are transferred to the heart surface at 
midgestation (E9.5–10.5 in the mouse)1,2. Initially epicardial cells conform a squamous single-layered epithelium 
completely covering the cardiac surface of the heart. From E11, epicardial cells undergo epithelial-mesenchymal 
transition (EMT) invading and colonizing the subepicardial space and the myocardium3–5. Epicardial-derived 
cells (EPDCs) contribute extensively to the myocardial connective tissues, extensively to smooth muscle and 
mesenchyme of the coronary vasculature and less so to the endothelium6–10. In the mouse, but not in other ver-
tebrates, the epicardium has also been reported to contribute to the cardiomyocyte lineage, however controversy 
remains as to whether these findings derive from undesired recombination of the epicardial Cre lines or represent 
true contributions8,10–12.
The Wilms’ tumor gene Wt1 is dynamically expressed in the coelomic epithelium as well as in coelomic 
epithelium-derived cells in many organs, including the epicardium, therefore several studies have used Wt1 as 
a lineage marker and tracer for the coelomic and coelomic-derived cells 10,13–18. Wt1 expression has also been 
reported in adult19 and embryonic endothelial and endocardial cells 12,20. Wt1 codes for a zinc-finger transcription 
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factor which has been involved in many normal and pathological processes21,22. The postnatal epicardium is 
normally quiescent, however it shows cellular and signaling activation upon injury in the fish and the mouse, 
contributing cells and signals that could be relevant in cardiac repair processes9,23–25.
Cell competition is a tissue homeostasis mechanism by which low-anabolizing -but otherwise viable- cells are 
eliminated from tissues due to confrontation with higher-anabolizing cells26–28. Increasing anabolism by moder-
ate Myc overexpression in a mosaic fashion leads to cardiomyocyte competition during cardiac development and 
adult myocardium homeostasis29. Cell competition leads to the homeostatic replacement of wild type cardiomyo-
cytes by the Myc-enhanced cardiomyocytes without producing any cardiac anatomical or functional alteration29.
Here we studied whether cell competition modifies the myocardial colonization pattern of EPDCs, determin-
ing the preferential expansion of Myc-enhanced epicardial cells in the niches usually colonized by EPDCs and in 
the cardiomyocyte lineage.
Results
Myc-overexpression in the WT1-Cre lineage promotes the extensive colonization of the 
myocardium during cardiac development. To study whether increased Myc levels modify the behav-
ior and contribution of the epicardial cell lineages, we used the Wt1Cre driver30 to induce recombination of the 
iMOST1-Myc and iMOSWT alleles. The iMOS alleles produce an initial 3:1 EYFP:ECFP mosaic28. The iMOSWT allele 
only expresses the fluorescent reporters and is used as control. The iMOST1-Myc allele is similar but overexpresses 
Myc in the EYFP cells. We analyzed the contribution of the EYFP population to the myocardium in E14.5 hearts. 
In histological sections, we found that EYFP-Myc cells in iMOST1-Myc hearts colonized a larger area than that col-
onized by their EYFP-wild type equivalent population in the iMOSWT mice (Fig. 1A–B’, E–G). These results were 
confirmed by cytometry (Fig. 1H). The greater contribution of the EYFP-Myc population was exacerbated at P0 
(Fig. 1C–D’), indicating that the EYFP-Myc cells continued their differential expansion during all cardiac prenatal 
development. The overcolonization by Myc-overexpressing cells did not induce any change in heart morphology 
or embryonic development in general.
We noticed that the expansion of the EYFP-Myc population involved the appearance of large patches of EYFP 
cardiomyocytes that were not observed in the control mosaics (Fig. 1A’–D’). To further characterize this phe-
nomenon we determined the differential enrichment of the EYFP population within the Wt1Cre-recombined 
ventricular cardiomyocyte compartment and in the non-cardiomyocyte compartment. We found that the EYFP 
population was moderately expanded in the non-cardiomyocyte compartment of E14.5 iMOST1-Myc hearts in com-
parison with iMOSWT hearts (Fig. 2A–B”, C–E). In the cardiomyocyte compartment, we observed a non-significant 
expansion of the EYFP-Myc population over that observed in the control mosaics in the inter-ventricular septum 
(Fig. 2D). The IVS was the only region in which we could detect Wt1Cre-recombined cardiomyocytes in control 
mosaics (Not shown). In iMOST1-Myc mosaics, however, we found extensive presence of iMOS+ cardiomyocytes 
in the RV and LV free walls, which were exclusively EYFP (Fig. 2C,E). These results suggested that most of the 
observed over-colonization of the ventricular myocardium is due to the appearance of EYFP cardiomyocytes 
in the free walls of the ventricles. This population is strictly dependent on the presence of Myc overexpression, 
as it was not observed in the control mosaic and did not include the ECFP population in the iMOST1-Myc hearts. 
To determine the relevance of differential proliferation in the colonization of the ventricles by EYFP-Myc car-
diomyocytes, we analyzed the frequency of Ph3+ cardiomyocytes in the EYFP+ and EYFP- populations of the 
Wt1Cre-recombined iMOST1-Myc mosaics. We detected higher proliferative activity of the EYFP-MYC cardiomyo-
cytes, in agreement with the observed over-colonization of the myocardium by this population (Fig. 2I).
Myc-overexpression in the WT1-Cre lineage increases epicardial cell migration and invasiveness, 
and promotes the progressive colonization of EPDC compartments. We then studied whether 
the expansion of EYFP-Myc cells resulted in an overall increase in the number of EPDCs. For this, we estab-
lished primary cultures from the LV at E14.5 and determined EYFP frequency in the cardiomyocyte and 
non-cardiomyocyte compartments (Fig. 2F,G). We found a moderate and non-significant increase of the overall 
abundance of EYFP cells within the non-cardiomyocyte compartment (Fig. 2H). In contrast, the cardiomyo-
cyte compartment showed a ~10-fold increase in EYFP cell frequency (Fig. 2H). These results show that while 
EYFP-Myc cells expand at the expense of ECFP cells within the EPDC compartment, they do not increase the 
overall contribution of EPDCs to the myocardium. In contrast, Myc overexpression modifies the contribution of 
the Wt1Cre lineage in the ventricles to extensively colonize the cardiomyocyte compartment.
To determine the sequence of enrichment in Myc cells during the development of the epicardial lineage, 
we analyzed the contribution of the EYFP compartment to the total iMOS+ population in the different regions 
colonized by this lineage. We found that the epicardium, the subepicardial space and the myocardium were 
all enriched in EYFP-Myc cells (Fig. 3A–C). To confirm these results we studied primary epicardial cultures 
from E10.5 ventricle explants and found that the EYFP compartment colonized close to 100% of these cultures 
(Fig. 3D–F). These results indicate the ability of Myc to expand epicardial cells at the expense of wild type cells 
both in vitro and in vivo from the earliest stages of epicardial development. We also observed that in vivo the 
enrichment in the sub-epicardial space was increased with respect to that observed in the epicardium, suggesting 
a higher invasive capacity of Myc-overexpressing cells. To investigate this behavior, we established a co-culture 
assay, exposing an explanted epicardium-less E9 WT ventricle to an E10.5 iMOS ventricle covered by epicar-
dium (Fig. 3G–J). In these assays, the epicardial cells migrated out from the “donor” ventricle and eventually 
reached the “receptor” ventricle (Fig. 3G–J). We performed these experiments using either Wt1Cre-recombined 
iMOST1-Myc or iMOSWT donors and observed higher migratory activity of the EYFP-Myc cells and a capacity to 
invade the receptor myocardium that was not observed for the EYFP-wild type cells (Fig. 3G–K).
We finally studied the contribution of the EYFP cells to the coronary vessels in the postnatal heart (P0) 
(Fig. 3L–O). At this stage we found variable contribution of iMOSWT-EYFP+ cells to the vessel layers, with limited 
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contribution to the intima (endothelium), strong contribution to the media (smooth muscle) and intermediate 
to the adventitia (fibroblasts) (Fig. 3L,M,P). The contribution was within a similar range for arteries and veins 
(Fig. 3P). We then examined the contribution of EYFP+ in iMOST1-Myc mosaics (Fig. 3P) and found no increase 
in the contribution to the intima, non-significant increase for the adventitia and venous media; however, we 
found a very significant increase in the contribution to the arterial media. Similarly, we found a very impor-
tant enrichment in EYFP-MYC endothelial cells in the microvasculature (Fig. 3P). We then studied whether the 
EYFP-Myc population had displaced the EYFP-CFP population in the WT1Cre-derived large vessel cell pop-
ulations and endothelium of the microvasculature. We determined the enrichment in EYFP+ cells within the 
iMOST1-Myc-derived cells (Fig. 3N,O) and found that the enrichment in all large vessel layers and endothelium 
of the microvasculature was close to 100% (Fig. 3Q) and clearly above that observed for the epicardium and 
Figure 1. Enhanced myocardial contribution by Myc-overexpressing cells. (A–B’) Confocal images from 
histological sections of iMOSWT (WT) (A) and iMOST1-Myc (MYC) (B) hearts at E14.5 induced with Wt1-Cre. 
(A’,B’) show magnification of the boxed areas shown in (A,B). (C–D’) Confocal images from histological sections 
of P0 iMOSWT (WT) (C) and iMOST1-Myc (MYC) (D) recombined with Wt1-Cre. (C’,D’) show magnification of 
the boxed areas shown in (C,D). (E–G) Quantification of the percentage of recombined area detected in iMOSWT 
(WT) and iMOST1-Myc (MYC) at E14.5 and P0 in the RV (E), IVS (F) and LV (G). (H) Cytometer histogram plot 
showing Counts (X axis) versus FITC laser (EYFP detection) in iMOSWT (WT) and iMOST1-Myc (MYC) E14.5 
whole digested hearts (upper panel). Lower panel shows quantification on EYFP population related to the total 
amount of live cells detected on the cytometer for iMOSWT (WT) and iMOST1-Myc (MYC) E14.5 hearts. Graphs in 
E, F, G, H show means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. Bar, 200 μ m in A, B, C, D and 50 in A’, B’, C’, D’ 
n ≥ 5 hearts for (A–G) and n ≥ 7 for (H).
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subepicardium (Fig. 3C). These results indicate that Myc promotes the progressive expansion of the epicardial 
lineages starting at the colonization of heart surface and continuously during the colonization of the myocardium 
and large vessels. This overcolonization takes place mostly at the expense of the WT epicardial-derived compart-
ment, as only mild expansion of the overall WT1Cre lineage was observed for the media and the intima, with the 
notable exception of the arterial smooth muscle layer and the endothelium of the microvasculature, in which Myc 
cells expanded further and replaced the non-EPDC compartment.
Wt1Cre-derived cardiomyocytes likely derive from early extra myocardial Wt1Cre-expressing 
cells and not from established epicardium. To investigate the origin of EYFP cardiomyocytes in the 
Wt1Cre-recombined iMOST1-Myc hearts, we induced recombination using a tamoxifen (TM)-inducible Cre driver 
(WT1CreERT2). This line has been reported before to induce limited recombination of the epicardium and to 
contribute to the cardiomyocyte lineage in one study15 but not in other12. Here we optimized the tamoxifen 
administration protocol to obtain around 50% recombination of the E14.5 epicardium. We administered TM 
at E9.5, which produced epicardial iMOS recombination at E10–10.5 (not shown), however contribution of 
iMOS+ cells to cardiomyocytes at E14.5 was neither observed in the control, nor in the Myc-expressing mosaics, 
even though EPDCs were detected (Fig. 4A,B’). These results suggested that Wt1Cre-derived cardiomyocytes do 
not derive from the epicardium and are in agreement with the absence of cardiomyocyte differentiation from 
Wt1Cre-recombined iMOST1-Myc epicardium in plain explants and in the co-culture assays (Fig. 3D,E’,G–J).
To further study this aspect, we analyzed pro-epicardial explants, which have been shown to partially differ-
entiate to the cardiomyocyte lineage (Fig. 4C,D’). Although we observed differentiation to cardiomyocytes in 
derivatives of the explanted proepicardia, EYFP-Myc and EYFP-wild type cells contributed equally to this lineage 
Figure 2. Preferential colonization of the cardiomyocyte lineage by Myc-overexpressing cells.  
(A–B’) Confocal images from histological sections of iMOSWT (WT) (A) and iMOST1-Myc (MYC) (B) hearts at 
E14.5 induced with Wt1-Cre. (A’,B’) show amplified regions from boxed areas in (A,B). (A”,B”) depict amplified 
regions from boxed areas in (A,B) showing native EYFP and anti-GFP staining. A”, solid indicates an EYFP-
negative, anti-GFP-positive cell and empty arrowhead indicates a double-positive cell. (C–E) Percentage of 
EYFP cells within the iMOS-positive population observed at E14.5 in whole hearts of the iMOSWT (WT) and 
iMOST1-Myc (MYC) mosaics in the non-cardiomyocyte fraction and in the cardiomyocyte fraction in the RV (C), 
IVS (D) and LV (E–G) Confocal images showing cultured cells from dissociated E14.5 hearts from iMOSWT 
(WT) (F) and iMOST1-Myc (MYC) embryos (G,H) Quantification of the proportion of EYFP cells within the non-
cardiomyocyte fraction (left graph) and cardiomyocyte fraction (right graph) from dissociated E14.5 hearts 
from iMOSWT (WT) and iMOST1-Myc (MYC) embryos. (I), Quantification of proliferation in cardiomyocytes of 
the WT1Cre lineage. Graph shows the frequency per area unit of Ph3+ cardiomyocytes in the EYFP- and EYFP+ 
populations of Wt1Cre;iMOST1-Myc newborn hearts. Frequencies were normalized to that observed in the EYFP- 
cardiomyocyte population. Graphs in (C–E,H,I) show means + SEM. *p < 0.05; **p < 0.01; ***p < 0.001. Bar, 
200 μ m in A, B, and 50 in (A’,B’,A”,B”) n ≥ 5 hearts.
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(Fig. 4C,D’), indicating that Myc overexpression does not enhance differentiation to cardiomyocytes in this assay 
(Fig. 4E).
We then investigated other possible origins of the Wt1Cre-labeled cardiomyocytes. Since cardiomyocytes are 
observed in the IVS of the Wt1Cre-recombined iMOSWT hearts, we considered the possibility that cell competi-
tion could stimulate the colonization of the ventricular free walls by expanding the original septal cardiomyocyte 
population. To explore this possibility, we recombined iMOSWT and iMOST1-Myc hearts with the AHFCre line, 
which produces recombination in the RV and IVS. Although we could observe local expansion of the EYFP-Myc 
population in E14.5 hearts, we did not detect colonization of the LV free wall as previously detected when using 
the Wt1Cre line (Fig. 4F,G), which discards septal cardiomyocytes as the origin of the LV free wall contribution 
of the Wt1Cre lineage.
We observed that the Wt1Cre line also recombined some hematopoietic cells and endocardial cells 
from early stages of cardiac development (Fig. 4H,H’). To explore whether these lineages could generate the 
Wt1Cre-recombined iMOST1-Myc cardiomyocytes, we used the Tie2Cre line, which recombines all endothelial and 
Figure 3. Progressive overcolonization of the epicardium and epicardial derivatives by Myc-overexpressing 
cells. (A–B’) Confocal images from histological sections of iMOSWT (WT) (A) and iMOST1-Myc (MYC) (B) hearts 
at E14.5 induced with Wt1-Cre. (A’,B’) show magnification of the boxed areas in (A) and (B). Co-localization 
of EYFP native fluorescence and anti-GFP immunofluorescence (in red) detects both ECFP (filled arrowheads) 
and EYFP (open arrowheads) cells. (C) frequency of EYFP cells with respect to total iMOS-recombined cells 
in epicardium (E), subepicardium (SE) and myocardium (MYO). Throughout the figure WT refers to iMOSWT 
mosaics and MYC to iMOST1-Myc mosaics. (D,E’) 6-day old epicardial cultures and magnifications (D’,E’).  
(F) Quantification of the EYFP frequency within the epicardial explants. (G,H) Co-culture of E10.5 epicardium 
and a WT E9.0 heart. (I,J), Similar cultures as shown in (G,H) showing a maximum fluorescence intensity 
projection (Z = 36 μ m). (*) indicates the WT heart and (E) the epicardial explant. Arrowhead shows invading 
EYFP-Myc epicardial-derived cells. K Quantification of epicardial cells per explant that colonize (Co) or invade 
(In) the WT myocardium. (L–O) Confocal image of histological sections from a P0 iMOST1-Myc heart showing 
EYFP-Myc perivascular colonization. (L–O) show the co-localization of vessel layer markers with alone or 
combined with EYFP and/or anti-GFP (red). EYFP+ cells, filled arrowheads, ECFP+ cells, open arrowheads. 
P and Q show the quantification of EYFP+ cell contributions as described in N,O. The graph above shows 
the absolute contribution of EYFP cells to the large vessel layers (In: intima, Me: media, Ad: adventitia) and 
endothelium of the microvasculature (En). Q shows the relative contribution of EYFP cells to the total iMOS+ 
population in iMOST1-Myc mosaics for the same cell types as in P. The blue line in Q shows the 75% contribution 
expected in case of neutral expansion of both populations. Graphs in C,F,K,P show means ± SEM. *p < 0.05; 
**p < 0.01; ***p < 0.001. Graph in Q shows means ± 95% confidence interval. Bar, 200 μ m in A,B,D,E, G–J and 
50 μ m in A’,B’,D’,E’,L,N. n ≥ 3 hearts in A–C, n ≥ 5 in D–F, n ≥ 3 in G–K and n = 5 in L–P.
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blood lineages in the mouse embryo. We did not observe any contribution of the Tie2Cre lineage to the cardio-
myocytes in E14.5 iMOST1-Myc hearts (Fig. 4H,H’), which discarded blood or endothelial precursors as the origin 
of Wt1Cre-derived cardiomyocytes.
We then studied the timing and site of appearance of Wt1Cre-recombined cardiomyocytes in iMOSWT and 
iMOST1-Myc hearts. We did not detect any iMOS+ cardiomyocytes before E9 (data not shown, N = 5), which dis-
cards recombination in early cardiac mesodermal precursors. The first EYFP cardiomyocytes were detected in 
both iMOSWT and iMOST1-Myc hearts between E9 and E9.5 before colonization by epicardial cells (Fig. 5A,B’). At 
this stage, the frequency of hearts containing EYFP cardiomyocytes was similar in iMOSWT and iMOST1-Myc hearts 
and the localization of EYFP cardiomyocytes in different regions of the developing heart is very variable but sim-
ilar in control and Myc mosaics (Fig. 5C). These results show that recombination of the cardiomyocyte lineage is 
induced by Wt1Cre in a scattered and non-stereotyped manner in both iMOSWT and iMOST1-Myc hearts and that 
Myc overexpression does not affect the initial pattern of recombined cardiomyocytes. In addition, these results 
show that the recombined cardiomyocytes should derive from WT1Cre-expressing cells before the establishment 
of the epicardium. To confirm this possibility, we induced Cre activity in the WT1CreERT2 line by TM injection 
at E8.0 and observed scattered recombined cardiomyocytes at E9.5 (Fig. 5D), contrary to what was observed fol-
lowing induction at later stages, in which no recombined cardiomyocytes were detected (Fig. 4A,B’).
We then tried to identify the original cells in which the recombination was produced and specifically whether 
cardiomyocytes undergo Cre recombination in situ. The fact that two different Cre lines driven by Wt1 regulatory 
sequences led to early cardiomyocyte recombination suggested that this activity could correspond to endogenous 
Wt1 expression. To explore this possibility, we studied in detail Wt1 protein expression in early cardiac formation, 
with a special emphasis on the stages in which Wt1Cre recombination was first observed (Fig. 6). The first Wt1+ 
cells were observed around E9 in the pericardial and proepicardial regions (Fig. 6B,B’ and data not shown), how-
ever, we did not detect any Wt1-positive cardiomyocyte between E8 and E14.5 (Fig. 6A,B’ and data not shown). 
To determine whether, independently of Wt1 expression, the Wt1Cre and Wt1CreERT2 lines used here produced 
Cre protein expression directly in cardiomyocytes, we performed antibody staining of Cre and CreERT2 proteins 
(Fig. 6C–F’). While Cre and CreERT2 could be clearly detected in the epicardium and pro-epicardium, both 
Figure 4. The Wt1Cre-recombined cardiomyocytes do not derive from the epicardium. (A,B) Confocal 
images of histological sections from E14.5 hearts iMOSWT (WT) (A) and iMOST1-Myc (MYC) (B); Wt1-Cre 
ERT2. A’,B’ show a magnification of the boxed areas shown in (A,B). (C–D’) Proepicardial explants cultured 
for 48 h from iMOSWT (WT) (C) and iMOST1-Myc (MYC) (D) where big clusters of beating cells were detected 
to be positive for cadiac TnT staining (arrowheads). E Quantification of the proportion of cardiomyocytes 
that expressed EYFP. (F,G) Confocal images from histological sections of Mef2C-AHF-Cre-recombined 
iMOSWT (WT) (F) and iMOST1-Myc (MYC) (G) mosaic hearts at E14.5. Arrowheads show the front of EYFP 
cardiomyocyte colonization. (H,H’) Confocal images from histological sections of iMOST1-Myc (MYC) E14.5 
heart induced with Tie2-Cre. H’ shows a magnification from the boxed area in (H). Graph in E shows means 
+ SEM. *p < 0.05; **p < 0.01; ***p < 0.001. Bar, 100 μ m in A,B,C,D,F,G,H and 20 μ m in A’,B’,C’,D’,H’, LA left 
atrium, LV left ventricle.
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proteins were completely absent from cardiomyocytes between E8 and E10 (Fig. 6C–F’). Altogether our results 
suggest that the observed recombined cardiomyocytes derive from extra-myocardial WT1Cre-expressing cells 
before the establishment of the epicardium.
Discussion
We reported here the ability of Myc moderate overexpression to provoke homeostatic cell population shifts dur-
ing the development of the epicardial lineage. Myc-induced preferential expansion took place from the first stages 
of epicardial development, being observable in primary cultures of E10.5-explanted epicardial cells, and further 
increased at various stages of epicardium and epicardial-derived cells development, including the myocardium 
invasion and the colonization of the vasculature. The tissues colonized by EPDCs have multiple origins, with 
EPDCs contributing to only a fraction of these tissues. Interestingly, in most cases we observed that the expan-
sion of EYFP-MYC cells occurred within the EPDC compartment of the colonized tissues, without displacing 
cells from other sources than EPDCs. Exceptions to these observations were the microvasculature endothelium 
and the arterial smooth muscle, where we observed clear overexpansion of the EPDC compartment with dis-
placement of cells from other origins. Interestingly arterial coronary smooth muscle, but not venous coronary 
smooth muscle receives a contribution from the neural crest31, suggesting MYC-stimulated EPDCs may be able to 
displace neural crest smooth muscle precursors but not those of different origins. Similarly, large part of the arte-
rial coronary endothelium is produced by budding of well-established endothelial sacs from the endocardium32, 
while the microvasculature is produced by other vasculogenic/angiogenic mechanisms. These differences in the 
mechanisms for the generation of endothelial populations may then underlie the different colonizing activity of 
Myc-stimulated EPDCs.
In part, the expansion of EYFP-MYC cells could take place by cell competition, however Myc-induced cell 
competition in mouse development involves close interactions between cells that are expected to take place 
in established tissues, like fully-colonized epicardium or vascular layers. In the case of epicardium-EPDC 
development, a very important additional step could be involved in the enrichment; cell migratory and inva-
sive ability. In fact, we observed that Myc cells showed enhanced migratory and myocardium-invasive abil-
ity in explant co-culture assays and the complete colonization of the vasculature by Myc-overexpressing 
cells may involve an enhanced migratory ability. These observations suggest that stimulating epicardial cell 
Figure 5. Myc overexpression does not affect the initial pattern of recombined cardiomyocytes (A,B) Confocal 
images of histological sections from E9.5 hearts iMOSWT (WT) (A) and iMOST1-Myc (MYC) (B) stained for c-TnT. 
A’ and B’ show magnification of boxed areas in (A–C), Graphs showing the proportion of embryos showing Wt1 
lineage contribution to cardiomyocytes in iMOSWT (WT) and iMOST1-Myc at stage E9.5 (left) and the distribution 
of Wt1 contribution to different areas of the heart in iMOSWT (WT) and iMOST1-Myc (MYC) at stage E9.5 (right). 
(D). Detection of Cre-recombined cardiomyocytes in the E9.5 heart following recombination induction at 
E8.0 in the Wt1-Cre ERT2 line. From left to right, images show MF20 expression, GFP detection and their co-
localization. Panels to the right show a magnification of the boxed area. Bar is 50 μ m. V, ventricle of the early 
cardiac tube. Graphs in (C) show means ± SEM. n ≥ 3 hearts in (A–C), n ≥ 5 in D.
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activity through homeostatic Myc overexpression may enhance the potential reparative ability of epicardium and 
epicardial-derived cells.
In addition, we observed widespread colonization of the ventricular free walls by Wt1Cre-derived cardiomy-
ocytes in Myc mosaics but not in control mosaics. However, a detailed study in cultured explants failed to show 
any ability of Myc to stimulate cardiomyocyte differentiation. Furthermore, Wt1CreERT2-recombined epicardial 
cells failed to contribute to the cardiomyocyte lineage, even when Myc was overexpressed. Given the ability of 
Myc to expand cardiomyocyte populations in the developing myocardium, even very minor initial contribu-
tions from the epicardial lineage to cardiomyocytes would have been expanded and easily detected. Our results 
thus strongly support the inability of Wt1+ epicardial cells to contribute to the cardiomyocyte lineage during 
development12 consistent with observations in other vertebrate models7,33. Based on our Cre and CreERT2 
expression analysis, we suggest that Cre activity in Wt1Cre-expressing precursors before epicardium adhesion to 
the ventricles could be the origin of cardiomyocyte lineage colonization, however we cannot completely exclude 
Figure 6. Cardiomyocyte recombination does not correlate with Cre or CreERT detection in cardiomyocytes 
(A,B) show immunofluorescence with anti-Wt1 and anti-SMA antibodies on sections of the developing cardiac 
tube of wild type embryos. (B’) shows a high magnification from the boxed area in (B). Arrowheads indicate 
pericardial Wt1+ cells. (C,D) show immunofluorescence with anti-Cre and anti-SMA antibodies on sections of 
the developing heart tube of Wt1Cre embryos. (D’) shows specific areas magnified from (D). Solid arrowheads 
indicate Cre-positive epicardial cells; empty arrowheads indicate Cre-positive pro-epicardial cells. (E,F) show 
immunofluorescence with anti-ER and anti-SMA antibodies on sections of the developing heart tube of 
Wt1CreERT2 embryos. (F’) shows specific areas magnified from F. Solid arrowheads indicate CreERT2-positive 
epicardial cells. Bar is 50 μ m in (A,B) and 100 μ m in (C–F).
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in situ cardiomyocyte recombination driven by undetectable levels of Cre protein expressed in cardiomyocytes. 
Our study of the Wt1Cre and Wt1CreERT2 lines thus suggests the exclusive use of the latter when aiming for 
targeting Wt1+ epicardial-derived lineages, with the caveat that also endocardial/endothelial cells express Wt1 
and undergo Cre-recombination in the WT1CreERT2 line12. Surprisingly, the initial pattern of Wt1Cre recom-
bination in cardiomyocytes is similar in control and Myc mosaics, however, at E14.5, cardiomyocytes in the free 
ventricular walls are only detectable in the Myc mosaics, while labeled cardiomyocytes in the IVS are observed 
in both. This pattern of colonization, and the in vitro studies reported here, indicate that Myc does not regulate 
the incorporation of Wt1Cre lineages to the cardiomyocyte pool, but differentially expands this initial popula-
tion. Interestingly, the epicardium is essential for proper IVS formation and has an important cellular contribu-
tion to the IVS in different species34, however contribution to the IVS cardiomyocytes has not been observed in 
Quail-Chick transplantation experiments34.
The overcolonization of the ventricles by EYFP-MYC cardiomyocytes in Myc mosaics continues progress-
ing until birth with up to 50% colonization (in some specimens) of the left ventricle free wall cardiomyocytes, 
while it remains barely detectable in control mosaics. Interestingly, the initial recombination pattern seems to 
affect more the derivatives of the first heart field (FHF) (See Fig. 1A), however at later stages, colonization of 
the RV progresses to reach the levels observed in the LV. Very likely this effect is related to the observation that 
Wt1Cre-promoted cardiomyocyte recombination takes place mostly during early cardiac stages, when only FHF 
cardiomyocytes are in place. In fact, using the AHFCre line, we observed expansion of second heart field (SHF) 
derivatives into the FHF-derived myocardium (Fig. 4G), indicating that Myc enhancement confers cardiomyo-
cytes the ability to violate the boundary between FHF and SHF.
Myc-driven phenotypically silent cell competition in cardiomyocytes has been previously reported, however 
the results reported here highlight the extraordinary ability of cell competition to stimulate small cardiomyocyte 
populations to colonize extensive areas of the myocardium. Our results suggest that cell competition stimulation 
could be useful for enhancing epicardial activation and cellular contributions to the myocardium. In addition, 
they highlight an extraordinary capacity of cell competition to expand scarce cardiomyocyte populations without 
altering cardiac anatomy.
Methods
Mouse Strains. All experiments were performed using mice (Mus musculus) of a mixed background that 
were maintained and handled according to the recommendations of the CNIC Ethics Committee, the Spanish 
laws and the EU Directive 2010/63/EU for the use of animals in research. The experimental protocols involving 
animals were approved by the CNIC and Universidad Autónoma de Madrid Committees for “Ética y Bienestar 
Animal” and the area of “Protección Animal” of the Comunidad de Madrid with reference PROEX 220/15.
iMOS Mouse lines have been previously described 28. Homozygous iMOS females were mated with males 
carrying different Cre lines.; Wt1Cre30, Mef2C-AHFCre35, Tie2Cre36 and Wt1Cre ERT2210 to generate embryos 
or pups. Mice were genotyped by PCR. To induce recombination in iMOS;Wt1CreERT2 mice, tamoxifen was 
administered by oral gavage (4 mg/mL). The Wt1GFP knockin line37, in which the exon 1 of one Wt1 allele has 
been replaced by the GFP sequence, was also used as an independent, reporter for active Wt1 transcription.
Embryonic epicardial explants. We followed previously described methods38. Briefly, to isolate epicardial 
cells from E10.5 and E11.5 embryos, hearts were dissected and the ventricles were each cut into two pieces. Each 
piece was placed with the epicardial outermost part facing down onto a gelatin covered MatTek Glass bottom Dish 
(0.1%Gelatin in PBS). These myocardial pieces were cultured in DMEM containing 10% FBS and 1% Penicillium 
Streptomycin. After 24 to 48 hours, epicardial cells had migrated from the explant and form a monolayer and the 
myocardial explant was removed using forceps. Epicardial cells were left to grow for 5 days, at which point they 
were visualized by confocal microscopy and/or fixed for immunostaining in 2%PFA overnight at 4 °C. Coexplant 
assays were performed in a similar way but adding a E9.0 heart in the dish close to the epicardial explant without 
contacting it.
Embryonic proepicardial explants. This method is extensively described in39. Embryos for proepicar-
dium explants were harvested at E9.0. The proepicardium was identified just under the heart as a “grape-like” 
clustering of cells. Heart tube was removed and discarded and proepicardial cells were removed. Proepicardial 
explants were cultured in DMEM 10% FBS 1% Penicillin-Streptomycin for 48 h on gelatin coated MatTek Glass 
bottom dishes.
Confocal microscopy. Histological sections and epicardial explants were imaged with a Nikon A1R con-
focal microscope using 405, 458, 488, 568 and 633 nm wavelenghts and 20x/0.75 dry and 40/1.30 oil objectives. 
Areas occupied by EYFP and ECFP cells and EYFP and ECFP cell number were quantified using the threshold 
detection and particle analysis tools of the Image J, (NHI, http://rsb.info.nih.gov/ij). To calculate the relative 
frequency of ECFP cells the percentage of ECFP cells in each embryo was divided by the average percentage in 
iMOSWT mosaic. ECFP was scored by substracting the information of EYFP from the anti-GFP staining which 
detects both fluorescent proteins.
Immunofluorescence. Embryos were obtained at different gestational stages, fixed overnight at 4 °C in 2% 
paraformaldehyde in PBS, gelatin embedded and cryosectioned. Embryonic epicardial and proepicardial explants 
were fixed in 2% PFA overnight at 4 °C and whole stained. Primary antibodies used were Wt1 (ab89901 abcam), 
Living colors Rabbit polyclonal anti GFP antibody (Clontech), c-TnT (MS-295 Thermo Scientific), PECAM-1 
(553370 BD Pharmingen™ clone MEC 13.3), SM22a (ab14106 abcam), SMA (C6198 Sigma), MF20 (DSHB), 
PH3 (06-570 Millipore), Cre (69050 Millipore) and ER (ab27595 abcam). For coronary vessel characterization, 
intima was detected with PECAM-1, media with SM22a and adventitia cells were identified by their mesenchymal 
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appearance and their disposition surrounding the media. Veins and arteries were identified by their position 
within the ventricle (veins more superficial and arteries more internal) and by the thickness and shape of the cells 
of the media, which are thin and fusiform in veins and thick and cuboidal in arteries. Identification with specific 
antibodies was not possible due to the need to detect 4 different channels in our experiments. In experiments 
in which both ECFP+ and EYFP+ positive cells were characterized, we found that ECFP was difficult to detect 
after section processing. We therefore detected all FPs with anti-GFP immunofluorescence and EYFP through its 
native fluorescence. Cells positive for anti-GFP and negative for EYFP were considered ECFP+.
Flow cytometer. Isolated cardiac cells from embryonic hearts were analyzed by flow cytometry to quantify 
EYFP population (ECFP was undetectable by flow cytometry). Propidium Iodide was added to the cells to asses 
viability (1:5000). An LSR Fortessa 4L Flow Cytometer was used for the analysis (Laser wavelengths 488, 640, 405, 
561). For the analysis, FACSDiva and FlowJo softwares were used.
Statistical analysis. To compare average percentages of ECFP cells between more than two groups, 
the Kruskal-Wallis test was used (assuming non-normal distributions). For comparisons of two groups a 
Man-Whitney U-test was used. All comparisons were made using Prism statistical software.
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Erratum: Myc overexpression 
enhances epicardial contribution to 
the developing heart and promotes 
extensive expansion of the 
cardiomyocyte population
Cristina Villa del Campo, Ghislaine Lioux, Rita Carmona, Rocío Sierra, Ramón Muñoz-Chápuli, 
Cristina Clavería & Miguel Torres
Scientific Reports 6:35366; doi: 10.1038/srep35366; published online 18 October 2016; updated on 09 December 
2016
The original version of this Article contained a typographical error in the title, where:
“Myc overexpression enhances of epicardial contribution to the developing heart and promotes extensive expan-
sion of the cardiomyocyte population”.
Now reads:
“Myc overexpression enhances epicardial contribution to the developing heart and promotes extensive expansion 
of the cardiomyocyte population”.
This has now been corrected in the HTML and PDF versions of this Article.
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